Oncogene

p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.

Oncogene

Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON, Sawyers CL

p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.

Oncogene

Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON, Sawyers CL

Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

Oncogene

Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E

Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

Oncogene

Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E

Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.

Oncogene

Van Etten RA, Debnath J, Zhou H, Casasnovas JM

Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.

Oncogene

Van Etten RA, Debnath J, Zhou H, Casasnovas JM

Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells.

Oncogene

Moasser MM, Reuter VE, Dmitrovsky E

Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells.

Oncogene

Moasser MM, Reuter VE, Dmitrovsky E

A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Oncogene

Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN

A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Oncogene

Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN

Pages